FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2321815482> ?p ?o ?g. }

• W2321815482 endingPage "423" @default.
• W2321815482 startingPage "414" @default.
• W2321815482 abstract "Idiopathic pulmonary fibrosis (IPF) is a rare and fatal restrictive respiratory disease under the idiopathic lung disease (ILD) class. IPF is a form of chronic, progressive fibrosing interstitial pneumonia and has more scarring, less inflammation, and poorer prognosis than most other ILD forms. Exacerbation of IPF is rapid, with unpredictable deterioration of lung function, and is associated with short-term mortality. The American Thoracic Society (ATS) evidence-based guidelines for diagnosis and management of IPF reports that the incidence of acute exacerbations is between 5%-10%. Limited real-world evidence has been identified in the United States that assesses patterns of hospitalization, exacerbation of IPF, and the associated economic burden.To (a) characterize patients newly diagnosed with IPF and (b) examine incidence rates and costs of all-cause hospitalizations, IPF-related hospitalizations, and exacerbations.A retrospective analysis was performed with a national commercial claims database from calendar years 2006 to 2011. Newly diagnosed IPF patients were identified with either ≥ 2 claims for idiopathic fibrosing alveolitis (IFA) or ≥ 1 claim for IFA and ≥ 1 claim for postinflammatory pulmonary fibrosis and a lung biopsy or thoracic high-resolution computed tomography within 90 days of the first claim for IFA (index date). IPF-related hospitalizations and possible IPF exacerbations were defined based on diagnoses recorded on event claims. Frequency, incidence rate, duration of events, and associated costs from the third-party payer's perspective were estimated.Among 1,735 identified IPF patients, 38.6% had at least 1 all-cause hospitalization; 10.8% had IPF-related hospitalizations; 4.6% had suspected IPF exacerbations leading to hospitalization; and 72.1% had suspected IPF exacerbations leading to urgent outpatient visits during the 1-year post-index period. Incident rates for these 4 events were 83 (95% CI = 79-88), 17 (95% CI = 14-19), 7 (95% CI = 6-9), and 277 (95% CI = 269-286) per 100 person-years, respectively. Average costs per event were $13,987 (SD = $41,988), $16,812 (SD = $66,399), $14,731 (SD = $85,468), and $444 (SD = $1,481), respectively.Hospitalizations and possible exacerbations among patients with IPF were costly. Appropriate management of IPF needs to be considered to help slow IPF disease progression.Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) provided funding for this study. Yu and Devercelli are currently salaried employees of BIPI. Wu, Chuang, Wang, Pan, and Benjamin are currently employees of Evidera, which provides consulting and other research services to pharmaceutical, device, government, and nongovernment organizations. In their salaried positions, they work with a variety of companies and organizations and are precluded from receiving payment or honoraria directly from these organizations for services rendered. Evidera received funding from BIPI to conduct the analysis. Coultas was previously a paid consultant of BIPI. The contents do not represent the views of the Department of Veterans Affairs or the U.S. government. This manuscript does not contain clinical studies or patient data. The authors have full control of all primary data, and they agree to allow the journal to review their data if requested. All authors meet the criteria for authorship as recommended by the International Committee of Medical Journal Editors, and they are fully responsible for all content and editorial decisions and were involved at all stages of manuscript development. The manuscript was drafted by Benjamin, Wu, and Yu and revised by Wang, Pan, Yu, Coultas, and Devercelli. The study was designed by Yu, Wu, Chuang, Wang, Benjamin, and Coultas. Statistical analysis was conducted by Wu, Chuang, and Wang. Senior review was provided by Coultas and Devercelli." @default.
• W2321815482 created "2016-06-24" @default.
• W2321815482 creator A5007180084 @default.
• W2321815482 creator A5011839521 @default.
• W2321815482 creator A5017610095 @default.
• W2321815482 creator A5020450763 @default.
• W2321815482 creator A5023213972 @default.
• W2321815482 creator A5041628864 @default.
• W2321815482 creator A5061078791 @default.
• W2321815482 creator A5078896966 @default.
• W2321815482 date "2016-04-01" @default.
• W2321815482 modified "2023-10-02" @default.
• W2321815482 title "Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis" @default.
• W2321815482 cites W1938547050 @default.
• W2321815482 cites W1970379805 @default.
• W2321815482 cites W1997256516 @default.
• W2321815482 cites W2013189749 @default.
• W2321815482 cites W2025372636 @default.
• W2321815482 cites W2051879911 @default.
• W2321815482 cites W2058041469 @default.
• W2321815482 cites W2066059923 @default.
• W2321815482 cites W2072029468 @default.
• W2321815482 cites W2072609284 @default.
• W2321815482 cites W2082191611 @default.
• W2321815482 cites W2086189310 @default.
• W2321815482 cites W2111256250 @default.
• W2321815482 cites W2124523627 @default.
• W2321815482 cites W2129168200 @default.
• W2321815482 cites W2134215992 @default.
• W2321815482 cites W2138871107 @default.
• W2321815482 cites W2140793587 @default.
• W2321815482 cites W2141474943 @default.
• W2321815482 cites W2142941142 @default.
• W2321815482 cites W2147335168 @default.
• W2321815482 cites W2157869208 @default.
• W2321815482 cites W2163279300 @default.
• W2321815482 cites W2163779649 @default.
• W2321815482 cites W2167189518 @default.
• W2321815482 cites W2167383172 @default.
• W2321815482 doi "https://doi.org/10.18553/jmcp.2016.22.4.414" @default.
• W2321815482 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27023695" @default.
• W2321815482 hasPublicationYear "2016" @default.
• W2321815482 type Work @default.
• W2321815482 sameAs 2321815482 @default.
• W2321815482 citedByCount "27" @default.
• W2321815482 countsByYear W23218154822017 @default.
• W2321815482 countsByYear W23218154822018 @default.
• W2321815482 countsByYear W23218154822019 @default.
• W2321815482 countsByYear W23218154822020 @default.
• W2321815482 countsByYear W23218154822021 @default.
• W2321815482 countsByYear W23218154822022 @default.
• W2321815482 countsByYear W23218154822023 @default.
• W2321815482 crossrefType "journal-article" @default.
• W2321815482 hasAuthorship W2321815482A5007180084 @default.
• W2321815482 hasAuthorship W2321815482A5011839521 @default.
• W2321815482 hasAuthorship W2321815482A5017610095 @default.
• W2321815482 hasAuthorship W2321815482A5020450763 @default.
• W2321815482 hasAuthorship W2321815482A5023213972 @default.
• W2321815482 hasAuthorship W2321815482A5041628864 @default.
• W2321815482 hasAuthorship W2321815482A5061078791 @default.
• W2321815482 hasAuthorship W2321815482A5078896966 @default.
• W2321815482 hasBestOaLocation W23218154821 @default.
• W2321815482 hasConcept C120665830 @default.
• W2321815482 hasConcept C121332964 @default.
• W2321815482 hasConcept C126322002 @default.
• W2321815482 hasConcept C167135981 @default.
• W2321815482 hasConcept C177713679 @default.
• W2321815482 hasConcept C2777014857 @default.
• W2321815482 hasConcept C2777405647 @default.
• W2321815482 hasConcept C2777524225 @default.
• W2321815482 hasConcept C2777543607 @default.
• W2321815482 hasConcept C2777714996 @default.
• W2321815482 hasConcept C2777914695 @default.
• W2321815482 hasConcept C2778341716 @default.
• W2321815482 hasConcept C2779563453 @default.
• W2321815482 hasConcept C2779832356 @default.
• W2321815482 hasConcept C2780171596 @default.
• W2321815482 hasConcept C61511704 @default.
• W2321815482 hasConcept C71924100 @default.
• W2321815482 hasConcept C75603125 @default.
• W2321815482 hasConceptScore W2321815482C120665830 @default.
• W2321815482 hasConceptScore W2321815482C121332964 @default.
• W2321815482 hasConceptScore W2321815482C126322002 @default.
• W2321815482 hasConceptScore W2321815482C167135981 @default.
• W2321815482 hasConceptScore W2321815482C177713679 @default.
• W2321815482 hasConceptScore W2321815482C2777014857 @default.
• W2321815482 hasConceptScore W2321815482C2777405647 @default.
• W2321815482 hasConceptScore W2321815482C2777524225 @default.
• W2321815482 hasConceptScore W2321815482C2777543607 @default.
• W2321815482 hasConceptScore W2321815482C2777714996 @default.
• W2321815482 hasConceptScore W2321815482C2777914695 @default.
• W2321815482 hasConceptScore W2321815482C2778341716 @default.
• W2321815482 hasConceptScore W2321815482C2779563453 @default.
• W2321815482 hasConceptScore W2321815482C2779832356 @default.
• W2321815482 hasConceptScore W2321815482C2780171596 @default.
• W2321815482 hasConceptScore W2321815482C61511704 @default.
• W2321815482 hasConceptScore W2321815482C71924100 @default.
• W2321815482 hasConceptScore W2321815482C75603125 @default.

• next